Health
Pfizer vaccine reduces rate of symptomatic infections by 94%, research shows – Ynetnews
Study also shows that a week after receiving the second dose, the vaccine is 91-99% efficient in preventing the pathogen from evolving into a serious illness results…
Research conducted by the Clalit Health Fund released Sunday shows that Pfizers coronavirus vaccine is exceptionally effective in preventing infection and severe illness in all age groups, including those aged 70 and over.
The study includes data on some 1.2 million Israelis insured by Clalit, of whom about 600,000 have received both doses of the Pfizers vaccine.
It shows a reduction of 94% in the rate of symptomatic infection and a reduction of 92% in the rate of serious illness among those who…
-
General9 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News18 hours agoRainbow Beach surfer’s untold 7/7 story
-
General24 hours agoWest Indies vs Australia live: Second Test, day three from Grenada
-
General23 hours agoDr Daniel Hunt, Michael Long and Christine Anu celebrated at 50th NAIDOC Week Awards